spacer
home > pmps > autumn 2017 > more than boxes and bottles
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

More than Boxes and Bottles

Although it is a common poison of choice in murder mysteries, arsenic was used as a cure for disease in the late Victorian era. From the questionable rituals of the Tudor period to lobotomies of the 1900s, throughout history we have seen too many crazy medical practices. Thankfully, today’s pharmaceutical industry is far more sophisticated and heavily regulated. However, it is not just medicine itself that has advanced, so has the pharma packaging designed to protect and store these products.

The pharma packaging market is currently experiencing an annual growth rate of around 5% a year and is now estimated to be worth over £15 billion. Nevertheless, as community and hospital pharmacies are under pressure to meet budgetary expectations, packaging selection can often fall to the bottom of the priority list.

Like other packaged goods, pharmaceuticals need reliable and cost-effective packaging solutions. However, the industry has more complex requirements for packaging than average consumer products. Due to the sensitive nature of the industry, pharmacists must pay careful attention when choosing their packaging options.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Oliver Pittock is the managing director of pharma packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

Partnerships in Clinical Trials Europe 2018

27-29 November 2018, CCIB, Barcelona

Partnerships in Clinical Trials Europe is back – and bigger than ever. Europe’s most complete clinical meeting is bringing together 1000+ of the industry’s leading experts this November for it’s 17th annual gathering, and you’re invited!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement